Add Company
Join Now

CV Therapeutics Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CV Therapeutics's estimated annual revenue is currently $123M per year.(i)
  • CV Therapeutics's estimated revenue per employee is $217,768

Employee Data

  • CV Therapeutics has 565 Employees.(i)
  • CV Therapeutics grew their employee count by -3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.8M512%$53MN/A
#2
$29.6M125-12%$110MN/A
#3
$0.4M25717%$236.7MN/A
#4
$21.5M114-23%$160MN/A
#5
$3.7M2111%N/AN/A
#6
N/A60150%N/AN/A
#7
$147.3M261-1%$192.5MN/A
#8
$16.6M88-1%$24.1MN/A
#9
$2.7M4018%N/AN/A
#10
$47.1M304-3%N/AN/A
Add Company

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.

keywords:N/A

N/A

Total Funding

565

Number of Employees

$123M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$107.8M57014%N/A
#2
$106.5M570-11%$506.6M
#3
$129.8M5843%N/A
#4
$300M5896%$263.3M
#5
$35M60021%N/A